Lu Yancen Net Worth

Lu Yancen biography

Lu Yancen serves as Independent Director of the Company. Mr. Lu has more than 20 years of experience in investment banking and equity investment management. He is the Founder and CEO of PagodaTree Partners, a healthcare PE fund. Before this, Mr.Lu was the Managing Director of Fountain Vest Partners. In addition to his professionalism in securities, investment and capital management, Mr. Lu has a special focus and comprehensive understanding of the global medical and healthcare industry. He served as Director of leading healthcare corporations including Sino Hospital Investment Corporation (Hong Kong), Chang’an Hospital (the largest private hospital in Northwest China), and DIH Medical Technologies. Mr. Lu received Bachelor’s and Master’s degrees in Engineering Economics from Tianjin University. Mr. Lu is qualified to serve as a director because of his extensive operational knowledge of, and executive level management experience in, the healthcare industry.

What is the salary of Lu Yancen?

As the Independent Director of Avalon GloboCare Corp, the total compensation of Lu Yancen at Avalon GloboCare Corp is $583,133. There are 4 executives at Avalon GloboCare Corp getting paid more, with Lu Wenzhao having the highest compensation of $4,047,220.

How old is Lu Yancen?

Lu Yancen is 45, he's been the Independent Director of Avalon GloboCare Corp since 2017. There are 10 older and 2 younger executives at Avalon GloboCare Corp. The oldest executive at Avalon GloboCare Corp is Wilbert Tauzin, 76, who is the Director.

What's Lu Yancen's mailing address?

Yancen's mailing address filed with the SEC is C/O AVALON GLOBOCARE CORP.,, 4400 ROUTE 9, SUITE 3100, FREEHOLD,, NJ, 07728.

Insiders trading at Avalon GloboCare Corp

Over the last 8 years, insiders at Avalon GloboCare Corp have traded over $2,500,000 worth of Avalon GloboCare Corp stock and bought 898,876 units worth $1,418,962 . The most active insiders traders include Wenzhao Lu, Luisa Ingargiola a Steven Andrew Sanders. On average, Avalon GloboCare Corp executives and independent directors trade stock every 157 days with the average trade being worth of $446,629. The most recent stock trade was executed by Wenzhao Lu on 1 April 2020, trading 645,161 units of AVCO stock currently worth $1,000,000.

What does Avalon GloboCare Corp do?

Avalon GloboCare Corp. is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX™), and regenerative therapeutics.

Avalon GloboCare Corp executives and stock owners

Avalon GloboCare Corp executives and other stock owners filed with the SEC include:

• Lu Wenzhao,
  Chairman of the Board of Directors
• Luisa Ingargiola,
  Chief Financial Officer
• David Jin,
  President, Chief Executive Officer, Director
• Li Meng,
  Chief Operating Officer, Secretary, Director
• Lu Yancen,
  Independent Director
• Dr. David K. Jin M.D., Ph.D.,
  CEO, Pres & Director
• Luisa Ingargiola,
  Chief Financial Officer
• Meng Li,
  COO, Sec. & Director
• Wilbert Tauzin,
  Director
• William Stilley,
  Independent Director
• Steven Sanders,
  Independent Director
• Tevi Troy,
  Independent Director
• Li Yue,
  Independent Director
• Steven Philip Sukel,
  Director